Beat-and-Raise With a Free Helium Option: The Thesis Is Warming, the Multiple Is Not

Results vs. Consensus

Year-over-Year (Q1 2026 vs. Q1 2025)

Sequential (Q1 2026 vs. Q4 2025)

The 50 bps sequential margin gain is the number that matters: management pricing and cost productivity more than offset the normal seasonal Q1 volume declines, exactly the self-help engine the thesis depends on.

Assessment — Revenue

The revenue beat is legitimate but, as in Q4, the underlying volume engine is only just turning over. Organic volume of 1% at the group level understates the improvement: management stressed that global base volume (ex project startups) turned positive for the first time this cycle, and the Americas posted 2% volume, its best since 2022. The offset remains EMEA, where underlying sales fell 2% on a 3% volume decline as European on-site customers shift production to more competitive assets in the Americas. Currency (+5%) will fade as a tailwind through the year; the question the top line poses is whether the Americas inflection broadens before FX rolls off.

Assessment — Margins

The adjusted operating margin of 30.0% was essentially flat YoY (down 10 bps) but rose 50 bps sequentially, and management raised its full-year margin-expansion ambition to "the upper end or even above" its 40–60 bps range. The quarter's regional mix was noisy: Americas margin expanded 60 bps to 31.6% and EMEA 60 bps to 36.1%, while APAC fell 130 bps to 28.0% on seasonal weakness plus lower-margin electronics sale-of-equipment tied to future merchant contracts. Management expects APAC to recover toward the 29% it ran last year. We read the margin trajectory as intact and the APAC dip as timing, not deterioration.

Assessment — EPS

Adjusted EPS of $4.33 (+10%, +5% ex-FX) is the cleanest print in our short coverage window: a beat versus consensus, a beat versus guide, and a floor-raise on the year. The +5% ex-FX growth is the honest organic number and sits below the company's 8–12% aspiration, a gap management attributed to the lingering helium/rare-gas drag and a ~1% engineering-timing drag, both of which it expects to lap. The important shift is directional: for the first time in the cycle, the levers pointing up (helium turning, Americas volume, electronics backlog) outnumber the ones pointing down. The stock reaction, a muted +1.4%, tells you the market already understood this.

Segment Performance

Americas

The Americas did the heavy lifting and delivered the quarter's most important data point: 6% underlying growth with 2% volume, led by electronics, manufacturing and metals & mining, at an expanding 31.6% margin. Management pointed to US hard goods up double digits, packaged gases up mid-single, Gulf Coast refining running hard on advantaged feedstock, and Latin American upstream benefiting from Brent economics. Metals is being helped by protectionist policy favoring local production and by the renewed competitiveness of gas-intensive blast furnaces.

"We have an engine here with a few cylinders. And 1 cylinder is Americas, 1 is APAC and 1 is EMEA. And we're not running on all 3 cylinders... in the Americas, both results and trends, I think, are positive." — Matthew White, CFO

Assessment: This is the cleanest evidence yet of a US industrial recovery flowing through Linde's leading indicators. If it broadens to APAC and Europe, the 0%-volume guide becomes a floor the company beats comfortably. For now, one cylinder is firing hard.

EMEA

EMEA remains the drag: underlying sales down 2% on a 3% volume decline in chemicals & energy and manufacturing, as Continental European on-site customers relocate production to feedstock-advantaged geographies. Yet, remarkably, the segment again posted the company's highest margin at 36.1%, up 60 bps. The Middle East conflict is adding both direct (small Middle East business) and indirect (energy-cost) pressure.

"EMEA continues to experience negative volumes, primarily from on-site customers shifting production to more competitive assets outside Continental Europe... we're not happy with the performance. The business team is taking actions to improve that." — Matthew White, CFO

Assessment: The 36.1% margin on falling volumes remains the standout proof of Linde's pricing and cost discipline. But the volume trajectory has no visible catalyst, and management is now openly dissatisfied. EMEA is the coiled spring and the persistent disappointment at once.

APAC

APAC grew 11% headline and 6% underlying, all volume, led by electronics and chemicals & energy plus the Jurong Island integrated complex startup. The 130 bps margin decline to 28.0% is the blemish, driven by Q1 seasonality and a slug of lower-margin electronics sale-of-equipment that carries future contracted merchant sales. Management expects a return toward 29%.

"About half of the sales growth was a sale of equipment... connected to long-term merchant contracts in electronics. So that does come with future contracted merchant sales. But that will tend to be a little bit lower margin on average." — Matthew White, CFO

Assessment: Strong volume with a temporary margin give-back that seeds future high-margin merchant revenue is a good trade. China is described as stable and India growing; APAC is the quiet second cylinder starting to hum.

Engineering

Engineering sales fell 8% to $517M, though margin rose to 19.5% and order intake jumped to $640M (from $434M in Q4) with a $2.8B third-party backlog. Management flagged a ~1% drag on group EPS growth from engineering project timing (internal capitalized work versus external for-profit projects).

Assessment: The revenue decline is timing, not demand, and the rising order intake points to a better second half. The margin improvement and backlog build are the more informative signals here.

Key Topics & Management Commentary

Overall Management Tone: Management was measured-but-warming, pairing a genuinely more constructive read on the Americas and helium with the same disciplined refusal to call a global recovery. The signature move of the quarter, raising the guidance floor while explicitly holding the top ("it's still early to signal increased optimism"), captures the posture precisely: more confident on resiliency, unwilling to underwrite optimism until more of the world is cooperating.

1. Helium: From Multi-Year Headwind to Free Option

The single biggest change from last quarter. Helium was in oversupply through 2025; the Middle East conflict, the Strait of Hormuz and Qatar disruption, plus a separate Russia-China dynamic, have created acute global shortages. Linde is 85–90% contracted, saw Q1 helium sales roughly flat YoY (price down a couple points, volume up a couple), and expects prices to rise and roll through as the year progresses. Crucially, none of this is in the guide.

"Recent events have created acute global shortages... the priority is to meet existing customer commitments. After that, we still anticipate excess molecules allowing us to pursue new multiyear contracts with high-quality customers... any incremental volumes or price would be upside." — Matthew White, CFO

Assessment: This converts a 1–2% EPS drag into an asymmetric upside option that costs an investor nothing at the guide. It is the most important reason the beat-and-raise cadence is likely to continue, and the clearest single catalyst for an eventual upgrade if it is formalized into guidance.

2. Geopolitics, Deglobalization and the Americas Advantage

The dominant macro frame was energy security and production relocation. Management sees activity moving to feedstock-advantaged assets in the Americas (and to a lesser extent APAC) and away from Continental Europe, a structural tailwind for its US Gulf Coast and Latin American positions.

"If your feedstock is coming in on a ship, it's probably a tough scenario for you. But if it's land-based... you're probably in a little bit better position, and that's kind of how I would say we're seeing it play out today." — Matthew White, CFO

Assessment: Linde's geographic footprint is well-aligned to a deglobalizing, energy-security-focused world. This is a slow-burn structural positive that reinforces the Americas cylinder and helps explain the region's volume inflection.

3. The Americas Volume Inflection Debate

With Americas volume at 2% and hard goods up double digits, management was pressed on whether this is the cyclical turn. The CFO leaned constructive on the Americas but declined to call a global recovery until all three regions align.

"At a global basis, while we showed 1% global volume, which is mostly our project backlog contribution, we did turn positive on base volumes. It's just not positive enough to round to 1%, but it has started to turn positive." — Matthew White, CFO

Assessment: Base volume turning positive is a genuine milestone after years of stagnation. Management's discipline in not over-claiming is credible, but the disclosure quietly upgrades the volume pillar from "absent" to "emerging."

4. Electronics Backlog and the "8 Handle"

Electronics grew 10%, the fastest end market, and management reiterated high confidence in adding substantial new projects this year, including large fab awards, while investing over $1B of backlog in ultra-high-purity plants.

"We're sitting a little over $7 billion right now, and I'd look to these being added... I'd fully expect us to have a higher backlog by the end of the year... could potentially have an 8 handle on it." — Matthew White, CFO

Assessment: The sale-of-gas backlog rising to $7.1B (versus the ~$5.5B some feared last quarter) plus an explicit "8 handle" target de-risks the backlog-replenishment concern that we flagged at Q4. The fab wins remain unsigned, so this stays a "show me," but the direction is right.

5. Woodside Project Timing Slip

On the large OCI/Woodside project, nitrogen remains on track to start mid-year, but the ATR and sequestration (TNS) portions have slipped a few months into Q1 2027 on challenging US Gulf Coast construction/subcontractor conditions.

"On the ATR and the TNS, that has slipped a few months into essentially Q1 of next year. The construction and subcontractor environment in the US Gulf Coast remains challenging." — Matthew White, CFO

Assessment: A modest negative, but contained: the atmospheric (nitrogen) piece still contributes in 2026 and the slip is execution timing, not cancellation. It trims a sliver of 2026 startup contribution and is a reminder that mega-project timing is lumpy.

6. Commercial Space Scaling Faster

Management hinted that commercial space could reach the 5%-of-sales (~$1.7B) disclosure threshold sooner than the prior "$1B by end of decade" framing, driven by launch frequency, rocket size and propellant type (hydrogen-based rockets would accelerate Linde's participation).

"When you add all the opportunities together... we feel pretty good about our ability to grow this business quite well. And really, it will just be a function of the space launch." — Matthew White, CFO

Assessment: Space optionality is expanding, but it remains a multi-year story and management is careful not to size it into near-term numbers. We continue to treat it as upside, not a 2026 driver.

7. Margin Ambition Raised

Management raised its full-year margin-expansion ambition to the upper end or above its 40–60 bps range, combining pricing, productivity and the prior restructuring.

"On a full year basis, we feel pretty confident we're not only going to raise margins for the full year 2026, but probably at the upper end or even above our traditional range... of 40 to 60 basis points." — Matthew White, CFO

Assessment: An explicit above-range margin commitment is the mechanism behind the raised EPS floor. It is achievable given the demonstrated self-help track record and is a rare piece of forward confidence in an otherwise guarded call.

8. EMEA: No Catalyst, Rising Frustration

Management characterized EMEA as structurally challenged, awaiting a catalyst (import restrictions or EU industrial-policy funds reaching the ground) and expressed open dissatisfaction with the region's performance.

"It really is going to come down to some catalyst to try and change that trajectory." — Matthew White, CFO

Assessment: EMEA is the one clearly-negative cylinder and the tone hardened this quarter. The high margin cushions the earnings impact, but a European volume turn is not in sight and management is not pretending otherwise.

9. The Earnings Algorithm and the Path Back to Double Digits

Asked about the gap between the 7–9% guide and the 8–12% aspiration, management pointed to the helium drag and a ~1% engineering-timing drag as the bridge, and committed to incremental actions (including buybacks) to close it.

"We know we need to get back to that 8% to 12% range, excluding macro... the algo is still intact, and we will take incremental actions if we need to bridge this further to help get us back to that double-digit EPS growth." — Matthew White, CFO

Assessment: The algorithm is intact and the drags are lapping. With helium now a tailwind rather than a headwind, the bridge back toward double digits looks more plausible than it did at Q4. This is the crux of the improving-thesis case.

10. Capital Allocation and the Fortress Balance Sheet

Linde returned $1.55B (including $800M of buybacks), reinvested ~$1.5B, signed 9 bolt-ons (primarily Americas), and raised the dividend 7% for a 33rd straight year at a 13% average growth rate.

"In periods of uncertainty and volatility like today, a fortress balance sheet is critical not only to maintain stability but also to capitalize on growth and share repurchase opportunities as they arise." — Juan Pelaez, Head of IR

Assessment: Unchanged and unimpeachable. The 9 bolt-ons in a single quarter show the acquisition machine is busy, and the ~1% top-line contribution from M&A remains a steady growth layer.

Guidance & Outlook

Management raised the FY floor by $0.20 to $17.60–$17.90 (midpoint ~$17.75, +7.8% on the $16.46 base) "from increased confidence in the overall business resiliency," while deliberately holding the top at $17.90 because "it's still early to signal increased optimism." Both the Q2 and full-year ranges assume a 1% FX tailwind and 0% economic improvement at the midpoint, and neither embeds any helium improvement versus February. That is the key subtlety: the raise came from confidence in the base business, with helium sitting on top as unbudgeted upside.

Implied quarterly ramp: With Q1 at $4.33 and Q2 guided to a $4.45 midpoint, the back half must average ~$4.48 to reach the $17.75 full-year midpoint, a gently back-loaded profile consistent with restructuring benefits and helium pricing building through the year.

Street at: Consensus sat near $17.80 for FY2026 and ~$4.45–$4.48 for Q2 entering the print. The Q2 guide midpoint ($4.45) is in line; the full-year midpoint ($17.75) is a hair below Street, but the floor-raise plus the excluded helium option is what the market rewarded.

Guidance style: Conservative-but-thawing. The floor-raise is the first upward revision in our coverage window; the held top and the excluded helium upside are classic Linde under-promising.

Analyst Q&A Highlights

Helium supply shock and the pass-through to contracts

By management's own account the most-asked topic of the call, questioning probed how the current helium shortage compares to the prior Russia-driven shock and how quickly pricing rolls through Linde's contracted book.

Q: "By far, the most incoming questions I'm getting on you guys is around helium... how do you see this supply shock playing out differently than what the Russian supply shock did and how long would the strait have to be closed before you'd start to see some of that pricing roll through some of your contractual business?"
— Duffy Fischer, Goldman Sachs

A: "We're anywhere from 85% to 90% contracted... global helium sales, for the most part, were roughly flat... we've been seeing the pricing rise on the average pricing... and likely that price will continue to go up and roll its way through. I fully would anticipate that to happen throughout the year... when opportunity presents itself both on pricing and volume, that will be incremental."
— Matthew White, CFO

Assessment: Management confirmed pricing is already rising and will roll through the contracted book over the year, and that it is entirely incremental to the guide. This is the single most valuable exchange for the forward earnings path.

Margin bridge: Americas up, Europe flat, APAC down

The opening question sought to decompose the quarter's margin moving parts and confirm the full-year expansion commitment.

Q: "My first question is on margins. You mentioned a strong improvement in the Americas, and I was wondering if you could talk about the big moving parts of why Europe was flat, Asia down. Is it helium? Is it the rapid cost inflation in March?"
— Laurent Favre, BNP Paribas

A: "On a full year basis, we feel pretty confident we're not only going to raise margins for the full year 2026, but probably at the upper end or even above our traditional range... of 40 to 60 basis points... I expect APAC to kind of get back up to the 29 type percent margins we saw last year."
— Matthew White, CFO

Assessment: Management framed APAC's dip as timing (seasonality + low-margin electronics equipment) and reaffirmed above-range full-year expansion. The margin story is intact; the quarterly noise is not a trend.

Is this the cyclical upswing?

With Americas volume at its best since 2022, questioning pressed on whether management had the confidence to call a cyclical turn.

Q: "I'm listening to you today talk about hard goods up double digits, energy and chemicals trending for the better. Do you have enough confidence to say we're now on the cyclical upswing? Or do you think there's too much war-related uncertainty?"
— Kevin McCarthy, Vertical Research Partners

A: "I always remain a little guarded... We're not running on all 3 cylinders. So while the Americas both results and trends are positive, we're just not seeing that in EMEA... to see a true global recovery, I'd like to see all 3 running in the same direction."
— Matthew White, CFO

Assessment: Management will not call the turn while EMEA lags, but conceded base volume has gone positive. The disciplined framing is credible and leaves clear upside if Europe joins.

Electronics contracts: still on track for FY26?

Questioning sought confirmation that the anticipated large electronics/fab awards remain live for 2026.

Q: "On electronics, I know you're expecting a couple of large contracts this year. Are they still in progress on the come for FY '26?"
— David Begleiter, Deutsche Bank

A: "We have a pretty high degree of confidence that we'll be announcing some here shortly... I'd fully expect us to have a higher backlog by the end of the year... could potentially have an 8 handle on it."
— Matthew White, CFO

Assessment: Confidence reiterated and quantified (potential "8 handle"). Still unsigned, so it stays a catalyst-to-watch, but the framing is more concrete than the "signature wins" tease at Q4.

Woodside status and 2026 contribution

Questioning sought clarity amid conflicting reports on the large Gulf Coast project's timeline.

Q: "...there's been some confusion... Can you level set us as to where you stand on that project and what's embedded in 2026 guidance?"
— David Begleiter, Deutsche Bank

A: "On the nitrogen, we still fully expect that... a pro rata start-up on the backlog this quarter. But on the ATR and the TNS, that has slipped a few months into essentially Q1 of next year. The construction and subcontractor environment in the US Gulf Coast remains challenging."
— Matthew White, CFO

Assessment: A candid timing slip on the higher-value hydrogen/sequestration phases, partly offset by the on-track nitrogen startup. Trims a sliver from 2026 but does not impair the project.

Geographic volume map and the US PMI

Questioning asked management to rank the regions given global disruption and to confirm whether the improving US PMI is showing up in the business.

Q: "Could you talk about the overall volume landscape across Asia, Europe and the Americas?... are you seeing any kind of benefits from what we've seen from positive PMIs in the last few months?"
— Josh Spector, UBS

A: "We are seeing improvements in Americas on the dislocation or shifting of product... And then APAC for us is relatively neutral to slightly positive... Our hard goods business is up double-digit percent right now in the US packaged business... you're absolutely seeing that positive benefit from the US PMI."
— Matthew White, CFO

Assessment: Management explicitly confirmed the US PMI improvement is flowing into hard-goods demand, the leading indicator it watches most closely. The clearest yes on the recovery question all call.

CEO absence from the call

An analyst directly asked whether the CFO-led format was a permanent change and whether the CEO was unavailable.

Q: "Could I ask if Sanjiv is not available today? Or is this the new format for the earnings call?... Wanted to make sure he knew he was missed."
— John Roberts, Mizuho

A: "If you may recall in the past, we've always kind of alternated... he's not on today, but he will definitely be on in a future call."
— Matthew White, CFO

Assessment: Management framed the CEO's absence as routine rotation, and the CFO's command of the detail was not in question. We note it but do not read a governance signal into a single quarter.

What They're NOT Saying

1. Helium upside deliberately unquantified: Management confirmed pricing is rising and will roll through, but declined to size the 2026 helium tailwind, keeping it as "incremental" optionality rather than a number. That preserves beat potential but leaves investors unable to model it.
2. The fab wins are still unsigned: For a second straight quarter, management is "highly confident" about imminent electronics/fab awards and now dangles an "8 handle" backlog, but nothing new is signed. The credibility clock is running.
3. Top-end of guidance held back: Management raised the floor but explicitly refused to touch the top "because it's still early." The asymmetry (confident enough to raise the floor, not the ceiling) is itself a statement about how much macro risk they still see.
4. CEO absent on a geopolitically pivotal quarter: With the Middle East conflict reshaping the helium and energy narrative, the CEO sat out the call. Framed as routine, but the timing is notable.
5. Insider selling unaddressed: Third-party data flagged insider sales with no buying over the trailing three months; management did not touch capital-allocation optics at the personal level, and no analyst raised it.

Market Reaction

• Pre-print setup: LIN closed at $501.14 on Apr 30 (the print hit before the open on May 1). The stock entered up 17.5% YTD and up 11.8% over the trailing 12 months, near the top of its $389.38–$510.75 52-week closing range, and had already outrun the S&P 500 (+5.3% YTD). Trailing-30-day performance was a more modest +1.5%, so some enthusiasm had cooled into the print.
• Reaction-day session (May 1, BMO): Shares gapped up 0.4% to $503.36, traded as high as $521.28 (+4.0%), and closed at $507.92, up 1.4% (+$6.78) on 2.6M shares versus a 2.3M 30-day average (1.1x). The S&P 500 was up 0.3% the same day, so the move was modestly stock-specific and positive.

The muted +1.4% reaction to a clean beat-and-raise says the good news was largely anticipated after an 18% YTD run. The intraday high near $521 shows the market briefly tried to price the helium optionality and the raised floor more aggressively before settling back. We read the action as constructive but expectations-constrained: the improving fundamentals are being met by a valuation that already reflects them, which is precisely the tension at the center of our Hold.

Street Perspective

Debate: How much is the helium option worth?

Bull view: An acute, potentially multi-quarter helium shortage against Linde's 85–90% contracted book is a durable pricing tailwind that management has deliberately left out of guidance, a free option that makes beats-and-raises the base case and could be formalized into a mid-year guide bump.

Bear view: Helium is a low-single-digit share of the portfolio; even a strong price cycle moves group EPS by a point or two, and the shortage could ease quickly if the Strait reopens or the Russia-China dynamic normalizes. It is a catalyst, not a re-rating event.

Our take: The bulls have the better of it on direction, the bears on magnitude. The option is real and asymmetric, but it is not large enough on its own to justify paying up at ~29x. It is the reason to keep watching, not yet the reason to buy.

Debate: Is the industrial cycle finally turning?

Bull view: Americas volume at its best since 2022, global base volume turning positive, US hard goods up double digits, and the US PMI confirmed flowing through, this is the leading edge of a broad industrial recovery that Linde's operating leverage (2021: 7–8% volume to 30% EPS) would amplify.

Bear view: It is one cylinder. EMEA is still contracting with no catalyst and management itself will not call a turn. This is the same "green shoots" investors have been sold for two years, and a European or oil-shock relapse would stall it.

Our take: The turn is real but narrow. We upgrade the volume pillar from "absent" to "emerging," but a one-cylinder recovery does not yet justify an above-market multiple. Broadening to APAC and Europe is the confirmation we need.

Debate: Does ~29x forward hold?

Bull view: Quality compounders with doubling backlogs, oligopoly pricing, a 33-year dividend streak and a free helium option rarely de-rate; the premium is warranted and the stock re-rates higher as the recovery broadens.

Bear view: ~29x forward and ~30x trailing on 7–9% EPS growth is a peak-ish multiple with a PEG well above 3x; any macro wobble or European relapse triggers multiple compression on a name priced for perfection.

Our take: The multiple is the governor on the rating. We would need a de-rating toward the mid-20s or a formalized helium/volume upgrade to numbers to turn constructive. At ~29x, the risk/reward is balanced, hence Hold.

Model Update Needed

Valuation impact: At the $507.92 reaction close, LIN trades at ~28.6x the raised FY26 midpoint and ~30x trailing adjusted EPS, with a ~1.3% dividend yield. We nudge our 12-month fair value to approximately $525 (roughly 29.6x the FY26 midpoint, crediting the helium option and volume inflection), about +3% from spot. Adding the yield, that is a market-perform total return, consistent with maintaining Hold. The improving fundamentals raise our conviction in the franchise, not our willingness to pay ~29x today.

Thesis Scorecard Post-Earnings

Overall: The thesis strengthened. Two of the three bear points eased (volume turning, guide raised) and a new asymmetric positive (helium) emerged, while all three bull pillars were confirmed or strengthened. The lone hardened negative is EMEA. On fundamentals alone this is trending toward an upgrade.

Action: Maintain Hold. The business is getting better, but the ~29x multiple after an 18% YTD run has already discounted much of the improvement. We raise conviction in the franchise and set a $525 fair value. The trigger for an upgrade is explicit: a formalized helium contribution in guidance, signed fab wins, or a broadening of the volume recovery to a second and third cylinder, especially if paired with any multiple pullback.